Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Randomized, Active Comparator Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

NCT04519645 is registered in ClinicalTrials.gov with UCB Biopharma SRL as lead sponsor.

NCT NCT04519645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Randomized, Active Comparator Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures
Lead sponsor
UCB Biopharma SRL
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2021
Completion date
October 31, 2024
Enrollment
29 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

electroencephalographic neonatal seizures, epilepsy